PepGen Inc. (PEPG) Form SCHEDULE 13D/A — Nov 17, 2026
RA Capital and its principals filed a Schedule 13D/A disclosing that its Healthcare Fund purchased 8,625,000 PepGen shares at $5.00 per share on November 13, 2026, for a total of $43.125 million, in PepGen's 25 million-share public offering. The purchase lifts RA Capital's aggregate beneficial ownership to 28,742,212 shares, or 30.5% of PepGen's common stock, based on 69,261,282 shares outstanding plus offering shares.
Key figures
- Shares Outstanding
- 69261282
- Percent owned
- 30.5%
- Offering shares issued
- 25000000
- Aggregate purchase price
- $43.125 million
- Purchase price per share
- $5.00
- Shares purchased in offering
- 8625000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.